Affiliation:
1. Xeptagen S.p.A., Via delle Industrie 9, 30175 Venice , Italy
Abstract
Abstract
The ageing process in the European society will become one of the key driving forces of change over the next decades. The specific demands of older generations constitute a key market of the future, and the pressure to improve and expand health services increases, especially as far as chronic diseases, such as cancer. Availability of cost effective cancer early detection protocols, based on predictive biomarkers, will improve patients management reducing consequently the high costs associated to treating patients when the disease is at an advanced stage.
Subject
Genetics,Molecular Biology,Biomedical Engineering,Molecular Medicine,Food Science,Biotechnology
Reference27 articles.
1. American Cancer Society, Global Cancer Facts & Figures 3rd Edition. 2015, American Cancer Society: Atlanta.
2. National Cancer Institute. Probability of Developing or Dying of Cancer. 2015 [cited 2016] ; Available from: srab.cancer.gov/devcan
3. Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncology. 2012. 13: 790-801.10.1016/S1470-2045(12)70211-5
4. Vollmers HP, Brandlein S. Natural antibodies and cancer. Journal of Autoimmunity. 2007. 29(4): 295-302.10.1016/j.jaut.2007.07.01317826951
5. Beneduce L, Prayer-Galletti T, Marcello Grimani Giustinian A, Gallotta A, Betto G, Pagano F, Fassina G. Detection of prostate specific antigen coupled to immunoglobulin M In prostate cancer patients. Cancer Detection and Prevention. 2007. 31: 402-407.1803550310.1016/j.cdp.2007.10.005
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献